House
File
794
H-1349
Amend
House
File
794
as
follows:
1
1.
By
striking
everything
after
the
enacting
clause
and
2
inserting:
3
<
Section
1.
Section
155A.46,
Code
2021,
is
amended
to
read
4
as
follows:
5
155A.46
Statewide
Administration
of
drugs
——
statewide
6
protocols.
7
1.
a.
A
pharmacist
may,
pursuant
to
statewide
protocols
8
developed
by
the
board
in
consultation
with
the
department
of
9
public
health
and
consistent
with
subsection
2
3
,
order
and
10
administer
the
following
to
patients
ages
eighteen
years
and
11
older:
12
(1)
a.
Naloxone.
13
(2)
b.
Nicotine
replacement
tobacco
Tobacco
cessation
14
products.
15
c.
Point-of-care
testing
and
treatment
for
influenza,
16
streptococcus
A,
and
COVID-19
as
defined
in
section
686D.2
at
17
the
point
of
interaction
between
a
pharmacist
and
a
patient.
18
d.
Point-of-care
testing
at
the
point
of
interaction
between
19
a
pharmacist
and
a
patient
in
response
to
a
public
health
20
emergency.
21
2.
a.
A
pharmacist
may
prescribe
and
administer
the
22
following
to
patients
ages
three
years
and
older:
23
(3)
(1)
An
immunization
or
vaccination
recommended
by
24
the
United
States
centers
for
disease
control
and
prevention
25
advisory
committee
on
immunization
practices
in
its
approved
26
vaccination
schedule
for
adults
.
27
(4)
(2)
An
immunization
or
vaccination
recommended
by
the
28
United
States
centers
for
disease
control
and
prevention
for
29
international
travel.
30
(5)
A
Tdap
(tetanus,
diphtheria,
acellular
pertussis)
31
vaccination
in
a
booster
application.
32
(3)
Vaccines
currently
licensed
for
use
in
the
United
33
States
on
the
list
issued
by
the
United
States
food
and
drug
34
administration,
including
those
related
to
COVID-19.
35
-1-
HF794.1801
(1)
89
(amending
this
HF
794
to
CONFORM
to
SF
296)
ss/rh
1/
4
#1.
(6)
(4)
Other
emergency
immunizations
or
vaccinations
in
1
response
to
a
public
health
emergency.
2
b.
A
pharmacist
may
,
pursuant
to
statewide
protocols
3
developed
by
the
board
in
consultation
with
the
department
of
4
public
health
and
consistent
with
subsection
2
,
order
prescribe
5
and
administer
the
following
to
patients
ages
six
months
and
6
older:
7
(1)
A
vaccine
or
An
immunization
or
vaccination
for
8
influenza.
9
(2)
Other
emergency
immunizations
or
vaccines
vaccinations
10
in
response
to
a
public
health
emergency.
11
c.
A
pharmacist
may,
pursuant
to
statewide
protocols
12
developed
by
the
board
in
consultation
with
the
department
13
of
public
health
and
consistent
with
subsection
2
,
order
and
14
administer
the
final
two
doses
in
a
course
of
vaccinations
for
15
HPV
to
patients
ages
eleven
years
and
older.
16
d.
c.
Prior
to
the
ordering
prescribing
and
administration
17
of
a
vaccination
or
an
immunization
or
vaccination
authorized
18
by
this
subsection
,
pursuant
to
statewide
protocols,
a
licensed
19
pharmacist
shall
consult
and
review
the
statewide
immunization
20
registry
or
health
information
network.
The
board
shall
21
adopt
rules
requiring
the
reporting
of
the
administration
of
22
vaccines
and
immunizations
and
vaccinations
authorized
by
this
23
subsection
to
a
patient’s
primary
health
care
provider,
primary
24
physician,
and
a
statewide
immunization
registry
or
health
25
information
network.
26
2.
3.
A
pharmacist
prescribing,
ordering
,
or
administering
27
a
prescription
drug,
product,
test,
or
treatment
pursuant
to
28
subsection
1
or
2
shall
do
all
of
the
following:
29
a.
Maintain
a
record
of
all
prescription
drugs,
products,
30
tests,
and
treatments
administered
pursuant
to
this
section
.
31
b.
Notify
the
patient’s
primary
health
care
provider
32
of
any
prescription
drugs,
products,
tests,
or
treatments
33
administered
to
the
patient,
or
enter
such
information
in
a
34
patient
record
system
also
used
by
the
primary
health
care
35
-2-
HF794.1801
(1)
89
(amending
this
HF
794
to
CONFORM
to
SF
296)
ss/rh
2/
4
provider,
as
permitted
by
the
primary
health
care
provider.
If
1
the
patient
does
not
have
a
primary
health
care
provider,
the
2
pharmacist
shall
provide
the
patient
with
a
written
record
of
3
the
prescription
drugs,
products,
tests,
or
treatment
provided
4
to
the
patient
and
shall
advise
the
patient
to
consult
a
5
physician.
6
c.
Complete
continuing
pharmacy
education
related
to
7
statewide
protocols
and
immunizations
and
vaccinations
8
recognized
and
approved
by
the
board.
9
Sec.
2.
NEW
SECTION
.
155A.47
Collaborative
pharmacy
10
practice
——
agreements
——
payment.
11
1.
For
the
purposes
of
this
section:
12
a.
“Collaborative
pharmacy
practice”
means
a
practice
of
13
pharmacy
whereby
a
pharmacist
provides
patient
care
and
drug
14
therapy
management
services
not
otherwise
permitted
to
be
15
performed
by
a
pharmacist
to
patients
under
a
collaborative
16
pharmacy
practice
agreement
with
another
pharmacist
or
17
practitioner
which
defines
the
nature,
scope,
conditions,
and
18
limitations
of
the
patient
care
and
drug
therapy
management
19
services
to
be
provided
by
a
pharmacist
in
order
to
ensure
that
20
a
patient
achieves
the
desired
outcomes.
21
b.
“Health
benefit
plan”
means
the
same
as
defined
in
22
section
514J.102.
23
c.
“Health
carrier”
means
the
same
as
defined
in
section
24
514J.102.
25
2.
Notwithstanding
any
provision
of
law
to
the
contrary,
a
26
pharmacist
may
engage
in
a
collaborative
pharmacy
practice,
in
27
accordance
with
rules
adopted
by
the
board
pursuant
to
chapter
28
17A
and
under
a
collaborative
pharmacy
practice
agreement,
to
29
provide
patient
care
and
drug
therapy
management
services
to
30
a
patient.
31
3.
Notwithstanding
any
provision
of
a
health
benefit
plan
32
to
the
contrary,
whenever
a
health
benefit
plan
provides
for
33
payment
or
reimbursement
for
a
service
that
is
within
the
34
lawful
scope
of
practice
of
a
practitioner
or
pharmacist
35
-3-
HF794.1801
(1)
89
(amending
this
HF
794
to
CONFORM
to
SF
296)
ss/rh
3/
4
and
the
service
is
provided
by
a
pharmacist
pursuant
to
a
1
collaborative
pharmacy
practice
agreement
under
this
section,
2
the
health
carrier
may
provide
payment
or
reimbursement
for
the
3
service.
>
4
______________________________
A.
MEYER
of
Webster
-4-
HF794.1801
(1)
89
(amending
this
HF
794
to
CONFORM
to
SF
296)
ss/rh
4/
4